<DOC>
	<DOCNO>NCT02370875</DOCNO>
	<brief_summary>Benign essential blepharospasm ( BEB ) functionally disable focal dystonia . Botulinum neurotoxin ( BoNT ) therapy suboptimal many BEB patient . Repetitious transcranial magnetic stimulation ( rTMS ) therapy promise noninvasive therapy show positive benefit BEB . rTMS therapy easily combine BoNT injection enhance effect BoNT BEB .</brief_summary>
	<brief_title>rTMS Botulinum Toxin Benign Essential Blepharospasm</brief_title>
	<detailed_description>A two week course rTMS therapy achieve sustain benefit employ . With standard BoNT treatment , peak-dose benefit see 4-6 week administration injection . rTMS introduce peak-dose period ( 6 week BoNT T1 ) .The effect combine therapy 10 week BoNT injection ( T2 ) 12 week BoNT injection ( T3 ) examine along physiological effect time point .</detailed_description>
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>subject diagnose blepharospasm craniocervical dystonia receive BoNT therapy Center Movement Disorders approach . The investigator enroll subject report experience positive benefit BoNT last 10 week less . pregnancy active seizure disorder significant cognitive impairment exposure neuroleptic presence metallic body pacemaker , implant , prosthesis , artificial limb joint , shunt , metal rod hear aid .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>